Literature DB >> 3207759

Prevention of calcium-induced membrane structural alterations in erythrocyte membranes by flunarizine.

P G Thomas1, A G Zimmermann, A J Verkleij.   

Abstract

The calcium antagonist flunarizine is shown to be able to prevent particle aggregation, membrane aggregation and blebbing resulting from elevated calcium concentrations. The anti-ischemic effects of flunarizine may therefore result in part from its ability to directly interfere with calcium-membrane interactions and thus prevent the lethal membrane reorganizations which occur after a period of ischemia during intracellular calcium overload.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207759     DOI: 10.1016/0005-2736(88)90421-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Comparison of the calcium entry and calcium overload blocking properties of R71811 and flunarizine.

Authors:  Y Matsui; I Yamagami; K Hirai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

2.  The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment.

Authors:  B D Kavanagh; B E Coffey; D Needham; R M Hochmuth; M W Dewhirst
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.